ישראל -
עברית -
Ministry of Health
אבולושן אלפא פארף קרם חמצן 6%
ג'ויה מעבדות לקוסמטיקה בעמ - רעיש תעיבצל עייסמ
ישראל -
עברית -
Ministry of Health
דלמאזין וטרינרי
romat ltd - cloprostenol-r 0.0075 %w/v - solution for injection - dalmazin is indicated for: estrus induction and synchronization in cows induction of parturition in cows sows and mares estrus induction in the mare ovarian dysfunction in the presence of the corpus luteum: post-partum anestrous condition silent estrus irregular cycle and cycle without ovulation persistent cl luteal cysts endometritis pyometra interruption of pregnancy (during first half) foetal mumification post-puerperal metropathy retarded uterine involution combined therapy of follicular cysts(10-14 days after administration of gnrh or hcg).
ישראל -
עברית -
Ministry of Health
ולטרקס טבליות 500 מג
glaxo smith kline (israel) ltd - valaciclovir as hydrochloride - טבליות מצופות פילם - valaciclovir as hydrochloride 500 mg - valaciclovir - valaciclovir - valtrex is indicated for the treatment of herpes zoster (shingles) in immunocopotent adults.valtrex accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. the efficacy of valaciclovir in immunocompromised patients has not been established. valtrex is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. valtrex is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). prophylaxis of cytomegalovirus infection and disease, following organ transplantation. for the treatment of cold sores (herpes labialis).
ישראל -
עברית -
Ministry of Health
ואלאציקלוביר טבע ® 500 מ"ג
teva pharmaceutical indust.ltd - valaciclovir hydrochloride (as dihydrate) 500 mg - film coated tablets - valaciclovir - valaciclovir teva is indicated for the treatment of herpes zoster (shingles) in immunocompetent adults . valaciclovir teva accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. the efficacy of valaciclovir teva in immunocompromised patients has not been established. - valaciclovir teva is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. - valaciclovir is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). - prophylaxis of cytomegalovirus infection and disease, following organ transplantation. - for the treatment of cold sores (herpes labialis).
ישראל -
עברית -
Ministry of Health
ולוויר
rafa laboratories ltd - valaciclovir as hydrochloride 500 mg - film coated tablets - valaciclovir - valovir is indicated for the treatment of herpes zoster (shingles) in immunocopotent adults. valovir accelerates the resolution of pain, it reduces the duration, and the proportion of patients with zoster-associated pain, which includes acute and post-herpetic neuralgia. the efficacy of valaciclovir in immunocompromised patients has not been established.valovir is indicated for the treatment of the initial and recurrent genital herpes due to herpes simplex infection. valovir is indicated for the prevention (suppression) of recurrent herpes simplex infections (herpes genitalis). prophylaxis of cytomegalovirus infection and disease, following organ transplantation. for the treatment of cold sores (herpes labialis).
ישראל -
עברית -
Ministry of Health
לוטמקס תרחיף
abic marketing ltd, israel - loteprednol etabonate - תרחיף לעין - loteprednol etabonate 5 mg / 1 ml - loteprednol - loteprednol - lotemax is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitides, when the inherent hazard of steroid use is accepted to otain an advisable diminution in edema and inflammation. lotemax is less effective than prednisolone acetate 1 % in two 28 day controlled clinical studies in acute anterior uveitis, where 72 % of patients treated with lotemax experienced resolution of anterior chamber cells, compared to 87 % of patients treated with prednisolone acetate 1 % . the incidence of patients with clinically significant increases in iop (> or = 10 mmhg) was 1 % with lotemax adn 6 % with prednisolone acetate 1 %. lotemax should not be used in patients who require a more potent corticosteroid for this indication. lotemax is also indicated for the treatment of po